272 related articles for article (PubMed ID: 18412854)
1. Pramipexole-induced psychosis in Parkinson's disease.
Li CT; Tsai SJ; Hwang JP
Psychiatry Clin Neurosci; 2008 Apr; 62(2):245. PubMed ID: 18412854
[No Abstract] [Full Text] [Related]
2. Dopaminergic psychosis in advanced Parkinson's disease.
Fischer P; Danielczyk W; Simanyi M; Streifler MB
Adv Neurol; 1990; 53():391-7. PubMed ID: 2122647
[No Abstract] [Full Text] [Related]
3. Zotepine in levodopa-induced Psychosis.
Spieker S; Stetter F; Klockgether T
Mov Disord; 1995 Nov; 10(6):795-7. PubMed ID: 8750001
[No Abstract] [Full Text] [Related]
4. Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy.
Melamed E; Zoldan J; Friedberg G; Ziv I; Weizmann A
Adv Neurol; 1996; 69():545-50. PubMed ID: 8615179
[No Abstract] [Full Text] [Related]
5. [Pathological gambling associated with pramipexole use in Parkinson's disease].
Lester J; Gonzalez-Aleman G; Zuniga-Ramirez C; Diaz-Pascuali SP; Raina-Castellino GB; Micheli-Gould F
Rev Neurol; 2006 Sep 1-15; 43(5):316-8. PubMed ID: 16941434
[No Abstract] [Full Text] [Related]
6. Clozapine treatment of psychosis in patients with Parkinson's disease.
Friedman JH
J Clin Psychiatry; 1994 Feb; 55(2):79. PubMed ID: 8077160
[No Abstract] [Full Text] [Related]
7. Pramipexole, ropinirole, and mania in Parkinson's disease.
Singh A; Althoff R; Martineau RJ; Jacobson J
Am J Psychiatry; 2005 Apr; 162(4):814-5. PubMed ID: 15800169
[No Abstract] [Full Text] [Related]
8. Pramipexole and gender identity disorder: expanding the phenotype of hypersexuality in Parkinson's disease.
Odiyoor M; Kobylecki C; Hackett RJ; Silverdale MA; Kellett MW
Mov Disord; 2009 Dec; 24(16):2434-5. PubMed ID: 19891000
[No Abstract] [Full Text] [Related]
9. Managing pathological gambling in Parkinson's disease with enteral levodopa/carbidopa infusions.
Gerschlager W; Bloem BR
Mov Disord; 2009 Sep; 24(12):1858-60. PubMed ID: 19514056
[No Abstract] [Full Text] [Related]
10. Telogen effluvium associated with the dopamine agonist pramipexole in a 55-year-old woman with Parkinson's disease.
Katz KA; Cotsarelis G; Gupta R; Seykora JT
J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S103-4. PubMed ID: 17052518
[No Abstract] [Full Text] [Related]
11. [Psychosis due to the interaction of erythromycin and bromocriptine in Parkinson disease].
Alegre M; Noé E; Martínez Lage JM
Neurologia; 1997 Nov; 12(9):429. PubMed ID: 9471184
[No Abstract] [Full Text] [Related]
12. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies.
Leentjens AF; Koester J; Fruh B; Shephard DT; Barone P; Houben JJ
Clin Ther; 2009 Jan; 31(1):89-98. PubMed ID: 19243709
[TBL] [Abstract][Full Text] [Related]
13. Increase in body weight after pramipexole treatment in Parkinson's disease.
Kumru H; Santamaria J; Valldeoriola F; Marti MJ; Tolosa E
Mov Disord; 2006 Nov; 21(11):1972-4. PubMed ID: 16972276
[TBL] [Abstract][Full Text] [Related]
14. Pramipexole in the treatment of Parkinson's disease: new developments.
Möller JC; Oertel WH
Expert Rev Neurother; 2005 Sep; 5(5):581-6. PubMed ID: 16162081
[TBL] [Abstract][Full Text] [Related]
15. Loss of color vision during long-term treatment with pramipexole.
Müller T; Przuntek H; Kuhlmann A
J Neurol; 2003 Jan; 250(1):101-2. PubMed ID: 12528002
[No Abstract] [Full Text] [Related]
16. [Treatment of pharmacotoxic psychoses with clopenthixol in patients with Parkinson's disease (author's transl)].
Danielczyk W
Wien Klin Wochenschr; 1981 Aug; 93(15):500-1. PubMed ID: 7303692
[TBL] [Abstract][Full Text] [Related]
17. Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.
Schindehütte J; Trenkwalder C
Clin Neurol Neurosurg; 2007 Feb; 109(2):188-91. PubMed ID: 16949733
[TBL] [Abstract][Full Text] [Related]
18. Managing psychosis in patients with Parkinson's disease.
Cummings JL
N Engl J Med; 1999 Mar; 340(10):801-3. PubMed ID: 10072418
[No Abstract] [Full Text] [Related]
19. [The treatment of Parkinson disease].
Jiménez-Jiménez FJ
Med Clin (Barc); 1999 Feb; 112(7):257-8. PubMed ID: 10220753
[No Abstract] [Full Text] [Related]
20. [Depressive syndrome, psychoses, dementia: frequent manifestations in Parkinson disease].
Wedekind S
MMW Fortschr Med; 2005 Jun; 147(22):11. PubMed ID: 15977623
[No Abstract] [Full Text] [Related]
[Next] [New Search]
